Kazunari Nakahara

Dr. Kazunari Nakahara

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2009 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
KNKazunari Nakahara
Kazunari Nakahara
JHJun Horaguchi
Jun Horaguchi
NFNaotaka Fujita
Naotaka Fujita
YNYutaka Noda
Yutaka Noda
GKGo Kobayashi
Go Kobayashi
OTOsamu Takasawa
Osamu Takasawa

Verified
Journal Article
Open access
PDF file
RSRyuta Shigefuku
Ryuta Shigefuku
HTHideaki Takahashi
Hideaki Takahashi
HNHiroyasu Nakano
Hiroyasu Nakano
TWTsunamasa Watanabe
Tsunamasa Watanabe
KMKotaro Matsunaga
Kotaro Matsunaga
MSMichihiro Suzuki
Michihiro Suzuki
The progression of chronic liver disease differs by etiology. The aim of this study was to elucidate the difference in disease progression between chronic hepatitis C (CHC) and nonalcoholic fatty liver disease (NAFLD) by means of fibrosis markers, liver function, and hepatic tissue blood flow (TBF). Xenon computed tomography (Xe-CT) was performed in 139 patients with NAFLD and 152 patients with CHC (including liver cirrhosis (LC)). The cutoff values for fibrosis markers were compared between NAFLD and CHC, and correlations between hepatic TBF and liver function tests were examined at each fibrosis stage. The cutoff values for detection of the advanced fibrosis stage were lower in NAFLD than in CHC. Although portal venous TBF (PVTBF) correlated with liver function tests, PVTBF in initial LC caused by nonalcoholic steatohepatitis (NASH-LC) was significantly lower than that in hepatitis C virus (C-LC) (p = 0.014). Conversely, the liver function tests in NASH-LC were higher than those in C-LC (p < 0.05). It is important to recognize the difference between NAFLD and CHC. We concluded that changes in hepatic blood flow occurred during the earliest stage of hepatic fibrosis in patients with NAFLD; therefore, patients with NAFLD need to be followed carefully.

28 August 2019 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
KNKazunari Nakahara
Kazunari Nakahara
YMYosuke Michikawa
Yosuke Michikawa
RMRyo Morita
Ryo Morita
KSKeigo Suetani
Keigo Suetani
NMNozomi Morita
Nozomi Morita
FIFumio Itoh
Fumio Itoh
Background and study aims Biliary plastic stents are generally substituted for gallbladder stents in endoscopic transpapillary gallbladder stenting (EGBS), there is no sufficient evidence about what type of plastic stent is suitable. We examined outcomes of EGBS using standard biliary stents and a novel stent for acute cholecystitis and evaluated the efficacy of the novel stent. Patients and methods Seventy patients with acute cholecystitis in whom EGBS was performed were evaluated retrospectively. We performed EGBS in 23 patients using the novel stent (novel stent group) and 47 patients using standard biliary stents (pigtail: 35, straight: 12) (control group). In the two groups, we examined outcomes of EGBS. Results There were no significant differences in patient backgrounds or rates of technical success, clinical success, or early adverse events (AE) between the novel stent group and the control groups. However, rates of late AEs were 4.3 % in the novel stent group (liver abscess: 1) and 40.4 % in the control group (stent migration: 15, recurrence of cholecystitis: 4), indicating a significantly higher rate in the control group (P = 0.004). The rate of stent migration was significantly higher in the control group (P = 0.006). Multivariate analysis identified a straight type stent as the risk factor for stent migration (odds ratio: 8.81, 95 % confidence interval: 1.66 – 46.83). Conclusions The novel stent had significantly lower rates of late AEs and stent migration. Thus, for long-term stent placement, the novel stent was more effective than traditional biliary stents.

1 January 2008 in Internal Medicine
Verified
Journal Article
Open access
PDF file
KNKazunari Nakahara
Kazunari Nakahara
GKGo Kobayashi
Go Kobayashi
NFNaotaka Fujita
Naotaka Fujita
YNYutaka Noda
Yutaka Noda
KIKei Ito
Kei Ito
TOTakashi Obana
Takashi Obana
An 18-year-old healthy woman was admitted to our department for further evaluation of a pancreatic mass (45 mm in diameter) by transabdominal ultrasound at a general health check. Solid-pseudopapillary tumor (SPT) was suspected from the findings of diagnostic images. Therefore, surgery was recommended. The patient and her family, however, refused surgery. Ultrasound-guided transcutaneous biopsy revealed proliferation of tumor cells with small nuclei showing a pseudopapillary arrangement. PAS positive granules and alpha-1-antitrypsin positive cells were proven, which led to the diagnosis of SPT. As the grade of atypism of the tumor cells was low, the patient underwent follow-up examination once a year at our outpatient department thereafter. The tumor gradually decreased its maximum diameter in 10 years from 45 mm to 15 mm. Thus far, there have been very few reports on the natural course of SPT, and this is the first report describing marked spontaneous shrinkage of a tumor in a long follow-up period.

18 February 2021 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
KNKazunari Nakahara
Kazunari Nakahara
JSJunya Sato
Junya Sato
RMRyo Morita
Ryo Morita
YMYosuke Michikawa
Yosuke Michikawa
KSKeigo Suetani
Keigo Suetani
FIFumio Itoh
Fumio Itoh

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
KNKazunari Nakahara
Kazunari Nakahara
COChiaki Okuse
Chiaki Okuse
NMNobuyuki Matsumoto
Nobuyuki Matsumoto
KSKeigo Suetani
Keigo Suetani
RMRyo Morita
Ryo Morita
FIFumio Itoh
Fumio Itoh
We present three cases of self-expandable metallic stent (SEMS) placement using a balloon enteroscope (BE) and its overtube (OT) for malignant obstruction of surgically reconstructed intestine. A BE is effective for the insertion of an endoscope into the deep bowel. However, SEMS placement is impossible through the working channel, because the working channel of BE is too small and too long for the stent device. Therefore, we used a technique in which the BE is inserted as far as the stenotic area; thereafter, the BE is removed, leaving only the OT, and then the stent is placed by inserting the stent device through the OT. In the present three cases, a modification of this technique resulted in the successful placement of the SEMS for obstruction of surgically reconstructed intestine, and the procedures were performed without serious complications. We consider that the present procedure is extremely effective as a palliative treatment for distal bowel stenosis, such as in the surgically reconstructed intestine.